Privia Health Group Inc (PRVA)

Privia Health Group Inc. is a U.S.-based healthcare company listed on NASDAQ under the ticker PRVA. The company operates as a national physician-enablement platform, working with physician practices, health plans, and health systems. Its services include technology and population health tools designed to support provider workflows, along with management services that help reduce administrative burden. Privia also operates a single-TIN medical group structure intended to support clinical integration, negotiation leverage, and alignment of incentives. In addition, the company provides accountable care organization capabilities focused on patient engagement, care coordination, and quality improvement within value-based care arrangements. Founded in 2007, Privia Health is headquartered in Arlington, Virginia.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-PRVA
$23.57
21.1% Upside
Undervalued
$31.67
62.7% Upside
Bargain
Great
0.0%
November 5, 2026
88.7x
3.2x
1.1x
2.486 B
2.148 B
0.3%
85.3%
4.9
466.3%
Valuation • Fair Value

Privia Health Group Inc (NASDAQ-PRVA) Fair Value by Valuation Model

Review the available estimates for Privia Health Group Inc (NASDAQ-PRVA), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$23.57

Estimated upside of 21.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$24.72

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.44

Classic Ben Graham valuation formula reference.

Comps Fair Value

$22.42

Comparable-company valuation reference.

Analyst Price Target

$31.67

Analysts imply upside of 62.7%.

How to read these valuation models

Use the 6 available valuation references for Privia Health Group Inc (NASDAQ-PRVA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Privia Health Group Inc (NASDAQ-PRVA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.358 B

Current operating scale indicator.

Revenue Forecast

2.45 B

Forward revenue estimate.

EBITDA

56.936 M

Current operating profitability reference.

EBITDA Forecast

152 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Privia Health Group Inc (NASDAQ-PRVA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Privia Health Group Inc (NASDAQ-PRVA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.54

No elevated caution signal from this screen.

Altman Z-Score

4.9

Relatively strong balance-sheet zone.

FCF / Net Income

466.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Privia Health Group Inc (NASDAQ-PRVA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Privia Health Group Inc (NASDAQ-PRVA)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

44

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Privia Health Group Inc (NASDAQ-PRVA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Privia Health Group Inc (NASDAQ-PRVA) Stock Forecast & Technical Outlook

Review Privia Health Group Inc (NASDAQ-PRVA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Privia Health Group Inc (NASDAQ-PRVA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Privia Health Group Inc (NASDAQ-PRVA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Privia Health Group Inc (NASDAQ-PRVA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Privia Health Group Inc (NASDAQ-PRVA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Privia Health Group Inc (NASDAQ-PRVA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Privia Health Group Inc (NASDAQ-PRVA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Privia Health Group Inc (NASDAQ-PRVA) has a Strong Buy consensus, with 13 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 13
Hold 1
Sell 0
FAQ Fast Investor Answers

Privia Health Group Inc (NASDAQ-PRVA) Stock FAQ

Data-supported answers about Privia Health Group Inc (NASDAQ-PRVA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$23.57
Estimated upside 21.1%
Valuation Rating
Undervalued
Estimated upside of 21.1%
Analyst Target
$31.67
Implied upside 62.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Privia Health Group Inc (NASDAQ-PRVA) is $23.57. This implies an estimated upside of 21.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 21.1% versus the current market price.

The available analyst price target for Privia Health Group Inc (NASDAQ-PRVA) is $31.67. The analyst target implies estimated upside of 62.7%.

The current financial health read for Privia Health Group Inc (NASDAQ-PRVA) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Privia Health Group Inc (NASDAQ-PRVA) is November 5, 2026.

The latest available data indicates no current dividend yield for Privia Health Group Inc (NASDAQ-PRVA).

The current P/E ratio listed for Privia Health Group Inc (NASDAQ-PRVA) is 88.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Privia Health Group Inc is 2.486 B.

The current enterprise value listed for Privia Health Group Inc is 2.148 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Privia Health Group Inc is NASDAQ-PRVA, and the stock is listed on NASDAQ.

Privia Health Group Inc (NASDAQ-PRVA) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Privia Health Group Inc is 0.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Privia Health Group Inc is 85.3%. Free float helps investors understand how much of the share base is available for public trading.